Aclaris Therapeutics (ACRS) Asset Utilization Ratio (2017 - 2026)

Aclaris Therapeutics' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.05 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 45.17% year-over-year to 0.05; the TTM figure through Mar 2026 stood at 0.05 (down 45.17% YoY), while the FY2025 annual figure was 0.04, down 54.14% from the prior year.
• Asset Utilization Ratio was 0.05 for Q1 2026 at Aclaris Therapeutics, roughly flat from 0.05 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.19 in Q2 2024 to a low of 0.02 in Q2 2022.
• Historically, Asset Utilization Ratio has averaged 0.1 across 5 years, with a median of 0.09 in 2024.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio soared 450.24% in 2023, then plunged 54.62% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2022, then surged by 31.93% to 0.15 in 2023, then tumbled by 38.15% to 0.09 in 2024, then sank by 49.89% to 0.05 in 2025, then climbed by 0.01% to 0.05 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.05 (Q1 2026), 0.05 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.